Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tepper

Showing results (411-420 of 432) with videos related to

Pageof 44
Sort By:
The Lancet. Neurology|April 19, 2025
Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trialCristina Tassorelli, Rigmor H Jensen, Peter J Goadsby, et al.
Obesity (Silver Spring, Md.)|January 14, 2012
Common variants in the CD36 gene are associated with oral fat perception, fat preferences, and obesity in African AmericansKathleen L Keller, Lisa C H Liang, Johannah Sakimura, et al.
Neurology|April 19, 2019
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trialStewart J Tepper, Hans-Christoph Diener, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache|November 12, 2019
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensionsMessoud Ashina, David Kudrow, Uwe Reuter, et al.
Headache|February 9, 2022
Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendationsStewart J Tepper, Huma U Sheikh, Carrie O Dougherty, et al.
Cephalalgia : an International Journal of Headache|June 28, 2019
Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysisIlse F de Coo, Juana Ca Marin, Stephen D Silberstein, et al.
Headache|May 20, 2022
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysisMessoud Ashina, Stewart J Tepper, Jan Lewis Brandes, et al.
International Journal of Clinical Practice|August 16, 2003
Establishing principles for migraine management in primary careA J Dowson, J Sender, S Lipscombe, et al.
Neurology|December 20, 2019
Vascular safety of erenumab for migraine preventionDavid Kudrow, Julio Pascual, Paul K Winner, et al.
Neurology|March 26, 2026
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION TrialRigmor Højland Jensen, Christofer Lundqvist, Henrik W Schytz, et al.
Pageof 44

Showing results (411-420 of 432) with videos related to

Sort By:
Pageof 44
The Lancet. Neurology|April 19, 2025
Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trialCristina Tassorelli, Rigmor H Jensen, Peter J Goadsby, et al.
Obesity (Silver Spring, Md.)|January 14, 2012
Common variants in the CD36 gene are associated with oral fat perception, fat preferences, and obesity in African AmericansKathleen L Keller, Lisa C H Liang, Johannah Sakimura, et al.
Neurology|April 19, 2019
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trialStewart J Tepper, Hans-Christoph Diener, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache|November 12, 2019
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensionsMessoud Ashina, David Kudrow, Uwe Reuter, et al.
Headache|February 9, 2022
Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendationsStewart J Tepper, Huma U Sheikh, Carrie O Dougherty, et al.
Cephalalgia : an International Journal of Headache|June 28, 2019
Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysisIlse F de Coo, Juana Ca Marin, Stephen D Silberstein, et al.
Headache|May 20, 2022
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysisMessoud Ashina, Stewart J Tepper, Jan Lewis Brandes, et al.
International Journal of Clinical Practice|August 16, 2003
Establishing principles for migraine management in primary careA J Dowson, J Sender, S Lipscombe, et al.
Neurology|December 20, 2019
Vascular safety of erenumab for migraine preventionDavid Kudrow, Julio Pascual, Paul K Winner, et al.
Neurology|March 26, 2026
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION TrialRigmor Højland Jensen, Christofer Lundqvist, Henrik W Schytz, et al.
Pageof 44